# Intas Pharmaceuticals Limited – FDA Inspection, Dec 14, 2018

Source: https://www.keypedia.com/records/fda_inspections/intas-pharmaceuticals-limited/fbcaf201-b95a-47b1-9d62-b65a4c37d203
Source feed: FDA_Inspections

> FDA inspection 1074349 of Intas Pharmaceuticals Limited, December 14, 2018. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 14 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1074349
- Company Name: Intas Pharmaceuticals Limited
- Inspection Date: 2018-12-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1245599 - 2024-07-12
- [FDA Inspection 1206170 - 2023-05-12](https://www.keypedia.com/records/fda_inspections/intas-pharmaceuticals-limited/cc06d269-7eb7-476e-8b4c-d7dbea9b39ff)
- [FDA Inspection 1098380 - 2019-08-02](https://www.keypedia.com/records/fda_inspections/intas-pharmaceuticals-limited/0895eb6a-065a-49a6-ac84-da712eda4358)
- FDA Inspection 1067525 - 2018-08-17
- [FDA Inspection 1056170 - 2018-06-08](https://www.keypedia.com/records/fda_inspections/intas-pharmaceuticals-limited/40778dca-3416-4505-9b4f-98131521219b)

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/intas-pharmaceuticals-limited/0db00702-d7f6-4a8b-87d1-1b32ac236cc8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
